1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Fulltext:  No Fulltext
Author:  Cebon, Jonathan S
Subject:  Animals

Results 1-10 of 10 (Search time: 0.006 seconds).

Publication YearTitleAuthor(s)
115-Jan-2014FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.Tan, BeeShin; Anaka, Matthew; Deb, Siddhartha; Freyer, Claudia; Ebert, Lisa M; Chueh, Anderly C; Al-Obaidi, Sheren; Behren, Andreas; Jayachandran, Aparna; Cebon, Jonathan S ; Chen, Weisan; Mariadason, John M 
21-Feb-2012Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile.Anaka, Matthew; Freyer, Claudia; Gedye, Craig; Caballero, Otavia; Davis, Ian D; Behren, Andreas; Cebon, Jonathan S 
318-Oct-2010Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.Wei, Joe; Waithman, Jason; Lata, Roleen; Mifsud, Nicole A; Cebon, Jonathan S ; Kay, Thomas; Smyth, Mark J; Sadler, Anthony J; Chen, Weisan
41-Mar-2010Cancer vaccines: Where are we going?Cebon, Jonathan S 
57-Nov-2009Cancer stem cells in urologic cancers.Gedye, Craig; Davidson, Adee-Jonathan; Elmes, Martin R; Cebon, Jonathan S ; Bolton, Damien M ; Davis, Ian D
615-May-2006Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.Jackson, Heather M; Dimopoulos, Nektaria; Mifsud, Nicole A; Tai, Tsin Yee; Chen, Qiyuan; Svobodova, Suzanne; Browning, Judy; Luescher, Immanuel F; Stockert, Lisa; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
71-Aug-2004A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples.Jackson, Heather M; Dimopoulos, Nektaria; Chen, Qiyuan; Luke, Tina; Yee Tai, Tsin; Maraskovsky, Eugene; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
815-Apr-2004NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors.Maraskovsky, Eugene; Sjölander, Sigrid; Drane, Debbie P; Schnurr, Max; Le, Thuy T T; Mateo, Luis; Luft, Thomas; Masterman, Kelly-Anne; Tai, Tsin-Yee; Chen, Qiyuan; Green, Simon; Sjölander, Anders; Pearse, Martin J; Lemonnier, Francois A; Chen, Weisan; Cebon, Jonathan S ; Suhrbier, Andreas
91-Jan-2003Rational approaches to human cancer immunotherapy.Davis, Ian D; Jefford, Michael; Parente, Phillip; Cebon, Jonathan S 
101-May-1997Clinical promise of tumour immunology.Scott, Andrew M ; Cebon, Jonathan S